semaglutide & tirzepatide alexandria Weight Loss Injections Clinics Near You Medical Weight Loss Houston |

Patients on Tirzepatide 15 mg weekly lost an average of 20.9% or 48.6 lb of their body weight after 72 weeks in the Zepbound Study 1 (NCT04184622) compared to placebo patients who lost an average of 3.1% or 7.2 lb

Note: Always follow your providers guidance for dosing adjustments and monitoring

Do you have materials I can use to educate my patients or colleagues about your studies

Wegovy is intended for use in adults with obesity (body mass index [BMI] of 30 kg/m or greater) or overweight individuals (BMI of 27 kg/m or greater) with at least one weight-related comorbidity, such as type 2 diabetes or high blood pressure